Medical companies that are still entertaining the notion that business can continue as usual – that somehow the model of collaboration between firms and physicians is enough to foster innovation – are in for a rude awakening. We live in the “mobile information age,” where customers patients aren’t tethered to bulky computers or laptops to do the necessary research on a treatment method that might be suitable for them. All they need to do is need pull out their smart phone or tablet and at the touch of an ap, they have about 75% of the information they have...
Aptus Endosystems (Sunnyvale, California), a company pioneering solutions to enhance aneurysm repair, reported positive initial results from its ANCHOR post-market registry evaluating the use of the Heli-FX EndoAnchor System in endovascular aneurysm repair (EVAR).
Coming off a successful approval from the FDA, OrthoSensor (Dania Beach, Florida) reported that it has received CE mark approval for its Verasense Knee System, and plans to launch the device in the European markets.
Unsustainable trends including aging demographics, chronic disease, cost of care, and caregiver shortage are driving a global healthcare crisis and even threatening the global economy. Wearable biosensor technology that remotely connects patients and caregivers is the force-multiplier to address these global challenges. The global market for biosensors to monitor health for aging, clinical, and consumer health will exceed $100 billion annually by 2015.
